DRIXINE NO DRIP FORMULA ORIGINAL PUMP MIST NASAL SPRAY oxymetazoline hydrochloride 500 ug/mL pump actuated metered dose aerosol

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

oxymetazoline hydrochloride, Quantity: 0.5 mg/mL

Available from:

Bayer Australia Ltd

INN (International Name):

oxymetazoline hydrochloride

Pharmaceutical form:

Spray, nasal

Composition:

Excipient Ingredients: disodium edetate; dibasic sodium phosphate; benzalkonium chloride; povidone; dispersible cellulose; monobasic sodium phosphate monohydrate; purified water; macrogol 1450; benzyl alcohol; Flavour

Administration route:

Nasal

Units in package:

15mL

Prescription type:

(S2) Pharmacy Medicine

Therapeutic indications:

Symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, flu, hayfever and sinusitis, and to facilitate visual intranasal examination. By decreasing congestion around the eustachian tube ostia, Drixine Nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Product summary:

Visual Identification: White to off-white, thick, gel-like suspension; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2009-11-16